- Home
- SXC vs SLS Comparison
SXC vs SLS Comparison
Compare SXC & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXC | SLS |
|---|---|---|
| Founded | 1960 | 2012 |
| Country | United States | United States |
| Employees | 848 | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 657.6M | 924.5M |
| IPO Year | 2011 | 2007 |
Fundamental Metrics
Financial Performance| Metric | SXC | SLS |
|---|---|---|
| Price | $8.89 | $9.27 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $9.00 | ★ $10.00 |
| AVG Volume (30 Days) | 1.7M | ★ 8.7M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | ★ 7.17% | N/A |
| EPS Growth | N/A | ★ 50.00 |
| EPS | N/A | N/A |
| Revenue | ★ $1,600,300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $110.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.30 | N/A |
| 52 Week Low | $5.52 | $1.39 |
| 52 Week High | $9.28 | $9.24 |
Technical Indicators
Market Signals| Indicator | SXC | SLS |
|---|---|---|
| Relative Strength Index (RSI) | 75.99 | 72.63 |
| Support Level | $7.70 | $3.72 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.34 | 0.88 |
| MACD | 0.13 | 0.24 |
| Stochastic Oscillator | 83.78 | 95.58 |
Price Performance
Historical ComparisonAbout SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.